TABLE 1:

Patient characteristics and primary motor cortex volume of activation measurements

Patient No./Age (y)/SexHistologic DiagnosisPrior SurgeryVoA (NT)VaO (T)Ratio (NT/T)
1/70/FGBMNo134534330.39
2/79/MGBMNo2854590.62
3/51/MGBMNo427149990.85
4/61/MGBMNo224623410.96
5/48/FGBMNo476244141.08
6/43/MGBMNo681951421.33
7/69/MGBMNo344922151.56
8/57/MGBMNo482530381.59
9/58/FGBMNo7914901.61
10/39/FGBMNo265815031.77
11/72/FGBMNo12023803.17
12/48/MGBMNo574312344.65
13/65/MMetastasisNo41148880.08
14/44/MMetastasisNo94939710.24
15/56/FMetastasisNo411348880.84
16/61/FMetastasisNo181915821.15
17/62/FMetastasisNo245220411.20
18/56/FMetastasisNo458835751.28
19/57/FMetastasisNo393930561.29
20/57/MMetastasisNo14406172.33
21/53/FMetastasisNo21208702.44
22/57/FMetastasisNo26267753.39
23/48/MMetastasisNo32127594.23
24/52/MOligodendroglioma, G-IIINo63315030.42
25/76/MAstrocytoma, G-IIINo21676963.11
26/43/MAstrocytoma, G-IINo113948250.24
27/36/FOligodendroglioma, G-IINo458855850.82
28/47/FAstrocytoma, G-IINo503150311.00
29/36/FOligoastrocytoma, G-IINo435131961.36
30/85/FMeningiomaNo175621360.82
Avg values of patients without prior surgery (n = 30)285826551.08
31/52/MGBMYes691318833.67
32/37/FGBMYes615414714.18
33/68/FGBMYes40506646.10
34/53/MMetastasisYes8076011.34
35/58/FMetastasisYes564821362.64
36/46/FMetastasisYes408219021.50
37/48/MAstrocytoma, G-IIIYes82318670.44
38/23/FAstrocytoma, G-IIIYes283210602.67
39/45/FOligodendroglioma, G-IIIYes29276346.25
40/31/MAstrocytoma, G-IIYes29748233.62
41/19/FOligodendroglioma, G-IIYes21522538.50
42/39/FAtypical meningiomaYes12186331.93
43/35/MLow-grade hemangiopericytomaYes416119462.14
Avg values of patients with prior surgery (n = 13)344210453.29
  • Note.—VoA indicates volume of activation (mm3); NT, nontumor side; T, tumor side; GBM, glioblastoma multiforme.